JP2013235610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013235610A5 JP2013235610A5 JP2013151434A JP2013151434A JP2013235610A5 JP 2013235610 A5 JP2013235610 A5 JP 2013235610A5 JP 2013151434 A JP2013151434 A JP 2013151434A JP 2013151434 A JP2013151434 A JP 2013151434A JP 2013235610 A5 JP2013235610 A5 JP 2013235610A5
- Authority
- JP
- Japan
- Prior art keywords
- library
- peptide
- antibody
- amino acid
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84903506P | 2006-10-02 | 2006-10-02 | |
| US60/849,035 | 2006-10-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531542A Division JP5473603B2 (ja) | 2006-10-02 | 2007-09-28 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013235610A JP2013235610A (ja) | 2013-11-21 |
| JP2013235610A5 true JP2013235610A5 (https=) | 2014-02-06 |
Family
ID=39269108
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531542A Active JP5473603B2 (ja) | 2006-10-02 | 2007-09-28 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
| JP2013151434A Pending JP2013235610A (ja) | 2006-10-02 | 2013-07-22 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
| JP2013259083A Pending JP2014077004A (ja) | 2006-10-02 | 2013-12-16 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531542A Active JP5473603B2 (ja) | 2006-10-02 | 2007-09-28 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013259083A Pending JP2014077004A (ja) | 2006-10-02 | 2013-12-16 | 多様な合成ペプチドおよびポリペプチドライブラリーの設計および構築 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US8131480B2 (https=) |
| EP (1) | EP2069558B1 (https=) |
| JP (3) | JP5473603B2 (https=) |
| CN (2) | CN103541018A (https=) |
| AU (1) | AU2007303572A1 (https=) |
| CA (1) | CA2664681C (https=) |
| DK (1) | DK2069558T3 (https=) |
| IL (1) | IL197837A (https=) |
| WO (1) | WO2008042754A2 (https=) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| EP2069558B1 (en) | 2006-10-02 | 2013-05-01 | Sea Lane Biotechnologies,llc. | Design and construction of diverse synthetic peptide and polypeptide libraries |
| CN101679974B (zh) | 2007-03-27 | 2015-09-30 | 航道生物技术有限责任公司 | 包含抗体替代轻链序列的构建体和文库 |
| EP3124497B1 (en) | 2007-09-14 | 2020-04-15 | Adimab, LLC | Rationally designed, synthetic antibody libraries and uses therefor |
| US12529164B2 (en) | 2007-09-14 | 2026-01-20 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| JP2009278908A (ja) * | 2008-05-22 | 2009-12-03 | Fujifilm Corp | 抗オステオカルシン抗体及びそれを用いた免疫測定方法 |
| JP5453613B2 (ja) * | 2008-09-30 | 2014-03-26 | 独立行政法人農業生物資源研究所 | 遺伝子クラスタリング装置およびプログラム |
| CA2761681A1 (en) | 2009-05-13 | 2010-11-18 | Sea Lane Biotechnologies, Llc | Neutralizing molecules to influenza viruses |
| WO2011028952A1 (en) | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| KR102318383B1 (ko) | 2010-07-16 | 2021-10-27 | 아디맵 엘엘씨 | 항체 라이브러리 |
| AU2011283694B2 (en) | 2010-07-29 | 2017-04-13 | Xencor, Inc. | Antibodies with modified isoelectric points |
| EP2640831A1 (en) | 2010-11-17 | 2013-09-25 | Sea Lane Biotechnologies,llc. | Influenza virus neutralizing agents that mimic the binding site of an influenza neutralizing antibody |
| EP2736928B1 (en) | 2011-07-28 | 2019-01-09 | i2 Pharmaceuticals, Inc. | Sur-binding proteins against erbb3 |
| US12466897B2 (en) | 2011-10-10 | 2025-11-11 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| US10851178B2 (en) | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| US9975956B2 (en) | 2011-12-22 | 2018-05-22 | I2 Pharmaceuticals, Inc. | Surrogate binding proteins which bind DR4 and/or DR5 |
| MX2014014199A (es) * | 2012-05-25 | 2015-02-12 | Bayer Healthcare Llc | Sistema y procedimiento de prediccion de la inmunogenicidad de un peptido. |
| US11053316B2 (en) | 2013-01-14 | 2021-07-06 | Xencor, Inc. | Optimized antibody variable regions |
| US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
| US9605084B2 (en) | 2013-03-15 | 2017-03-28 | Xencor, Inc. | Heterodimeric proteins |
| KR102211837B1 (ko) | 2013-01-14 | 2021-02-03 | 젠코어 인코포레이티드 | 신규한 이형이량체 단백질 |
| US10131710B2 (en) | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
| US9701759B2 (en) | 2013-01-14 | 2017-07-11 | Xencor, Inc. | Heterodimeric proteins |
| US10968276B2 (en) | 2013-03-12 | 2021-04-06 | Xencor, Inc. | Optimized anti-CD3 variable regions |
| WO2014113510A1 (en) | 2013-01-15 | 2014-07-24 | Xencor, Inc. | Rapid clearance of antigen complexes using novel antibodies |
| EP2970486B1 (en) | 2013-03-15 | 2018-05-16 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
| US10519242B2 (en) | 2013-03-15 | 2019-12-31 | Xencor, Inc. | Targeting regulatory T cells with heterodimeric proteins |
| US10858417B2 (en) | 2013-03-15 | 2020-12-08 | Xencor, Inc. | Heterodimeric proteins |
| US10106624B2 (en) | 2013-03-15 | 2018-10-23 | Xencor, Inc. | Heterodimeric proteins |
| WO2015100409A2 (en) | 2013-12-26 | 2015-07-02 | Tufts University | Methods, compositions and kits for treating a subject using a recombinant neutralizing binding protein |
| EP3699195A3 (en) | 2014-03-28 | 2020-11-04 | Xencor, Inc. | Bispecific antibodies that bind to cd38 and cd3 |
| EP3223907A2 (en) | 2014-11-26 | 2017-10-04 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and cd38 |
| US10259887B2 (en) | 2014-11-26 | 2019-04-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
| PE20171324A1 (es) | 2014-11-26 | 2017-09-11 | Xencor Inc | Anticuerpos heterodimericos que se unen a cd3 y a antigenos tumorales |
| WO2016105450A2 (en) | 2014-12-22 | 2016-06-30 | Xencor, Inc. | Trispecific antibodies |
| EP3253793A4 (en) | 2015-02-02 | 2018-11-14 | i2 Pharmaceuticals, Inc. | Anti-surrogate light chain antibodies |
| US10227411B2 (en) | 2015-03-05 | 2019-03-12 | Xencor, Inc. | Modulation of T cells with bispecific antibodies and FC fusions |
| EP4282979A3 (en) | 2015-09-01 | 2024-02-28 | The Regents of the University of California | Modular polypeptide libraries and methods of making and using same |
| CA3007030A1 (en) | 2015-12-07 | 2017-06-15 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and psma |
| JP7010854B2 (ja) | 2016-06-14 | 2022-01-26 | ゼンコア インコーポレイテッド | 二重特異性チェックポイント阻害剤抗体 |
| CN109715663B (zh) | 2016-06-28 | 2022-11-25 | Xencor股份有限公司 | 结合生长抑素受体2的异源二聚抗体 |
| US10793632B2 (en) | 2016-08-30 | 2020-10-06 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| EP3293293A1 (en) * | 2016-09-08 | 2018-03-14 | Italfarmaco SpA | Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distribution |
| MY203000A (en) | 2016-10-14 | 2024-06-01 | Xencor Inc | Il15/il15r� heterodimeric fc-fusion proteins |
| WO2018129425A1 (en) * | 2017-01-06 | 2018-07-12 | Igc Bio, Inc. | System and method for generating antibody libraries |
| WO2019006472A1 (en) | 2017-06-30 | 2019-01-03 | Xencor, Inc. | TARGETED HETETRODIMERIC FUSION PROTEINS CONTAINING IL-15 / IL-15RA AND ANTIGEN-BINDING DOMAINS |
| US10981992B2 (en) | 2017-11-08 | 2021-04-20 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| JP2021502100A (ja) | 2017-11-08 | 2021-01-28 | ゼンコア インコーポレイテッド | 新規抗ｐｄ−１配列を用いた二重特異性および単一特異性抗体 |
| US11034951B2 (en) | 2017-11-20 | 2021-06-15 | Nantbio, Inc. | mRNA display antibody library and methods |
| US11015188B2 (en) | 2017-11-20 | 2021-05-25 | NantBio Inc. | MRNA display antibody library and methods |
| IL275426B2 (en) | 2017-12-19 | 2025-03-01 | Xencor Inc | Engineered il-2 fc fusion proteins |
| CA3096052A1 (en) | 2018-04-04 | 2019-10-10 | Xencor, Inc. | Heterodimeric antibodies that bind fibroblast activation protein |
| EP3781598A1 (en) | 2018-04-18 | 2021-02-24 | Xencor, Inc. | Tim-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and tim-3 antigen binding domains |
| SG11202010163QA (en) | 2018-04-18 | 2020-11-27 | Xencor Inc | Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof |
| AU2019355971B2 (en) | 2018-10-03 | 2025-05-08 | Xencor, Inc. | IL-12 heterodimeric Fc-fusion proteins |
| CA3132185A1 (en) | 2019-03-01 | 2020-09-10 | Xencor, Inc. | Heterodimeric antibodies that bind enpp3 and cd3 |
| EP3767628B1 (de) * | 2019-07-18 | 2024-03-27 | Bayer Aktiengesellschaft | Selektion von antikörpern / antikörperfragmenten |
| WO2021115468A1 (zh) * | 2019-12-13 | 2021-06-17 | 南京金斯瑞生物科技有限公司 | 一种构建抗体互补决定区文库的方法 |
| WO2021231976A1 (en) | 2020-05-14 | 2021-11-18 | Xencor, Inc. | Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3 |
| US11739144B2 (en) | 2021-03-09 | 2023-08-29 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and CLDN6 |
| EP4305065A1 (en) | 2021-03-10 | 2024-01-17 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and gpc3 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US7067284B1 (en) | 1992-01-27 | 2006-06-27 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| US7264963B1 (en) | 1995-08-18 | 2007-09-04 | Morphosys Ag | Protein(poly)peptide libraries |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| ATE421976T1 (de) * | 1999-05-18 | 2009-02-15 | Dyax Corp | Fab fragmentbibliotheken und verfahren für deren verwendung |
| AU8653901A (en) | 2000-08-18 | 2002-03-04 | Massachusetts Inst Technology | Apparatus and methods for the automated synthesis of oligosaccharides |
| EP1390741B1 (en) * | 2001-04-17 | 2012-10-31 | Abmaxis, Inc. | Structure-based construction of human antibody library |
| WO2003099999A2 (en) | 2002-05-20 | 2003-12-04 | Abmaxis, Inc. | Generation and selection of protein library in silico |
| CA2488441C (en) | 2002-06-03 | 2015-01-27 | Genentech, Inc. | Synthetic antibody phage libraries |
| MXPA05009805A (es) | 2003-03-14 | 2006-04-18 | Celltech R & D Inc | Ligandos para proteinas de enlace tgf-beta y usos de los mismos. |
| BRPI0412007A (pt) * | 2003-06-27 | 2006-08-15 | Bioren Inc | mutagênese look-through |
| CA2562034A1 (en) | 2004-03-31 | 2005-10-20 | Jin Lu | Method and apparatus for analyzing and generating human antibody amino acid and nucleic acid sequences |
| ES2563491T3 (es) * | 2004-07-06 | 2016-03-15 | Bioren, LLC | Bibliotecas universales de anticuerpos |
| AU2006210660B2 (en) * | 2005-02-01 | 2011-12-01 | Morphosys Ag | Libraries and methods for isolating antibodies |
| EP2069558B1 (en) | 2006-10-02 | 2013-05-01 | Sea Lane Biotechnologies,llc. | Design and construction of diverse synthetic peptide and polypeptide libraries |
-
2007
- 2007-09-28 EP EP07843450.3A patent/EP2069558B1/en active Active
- 2007-09-28 CA CA2664681A patent/CA2664681C/en not_active Expired - Fee Related
- 2007-09-28 DK DK07843450.3T patent/DK2069558T3/da active
- 2007-09-28 AU AU2007303572A patent/AU2007303572A1/en not_active Abandoned
- 2007-09-28 CN CN201310472612.6A patent/CN103541018A/zh active Pending
- 2007-09-28 WO PCT/US2007/079849 patent/WO2008042754A2/en not_active Ceased
- 2007-09-28 US US11/864,525 patent/US8131480B2/en active Active
- 2007-09-28 JP JP2009531542A patent/JP5473603B2/ja active Active
- 2007-09-28 CN CN2007800446133A patent/CN101548034B/zh not_active Expired - Fee Related
-
2009
- 2009-03-26 IL IL197837A patent/IL197837A/en not_active IP Right Cessation
-
2011
- 2011-12-09 US US13/374,065 patent/US20120202716A1/en not_active Abandoned
- 2011-12-14 US US13/374,203 patent/US20120129731A1/en not_active Abandoned
-
2013
- 2013-07-22 JP JP2013151434A patent/JP2013235610A/ja active Pending
- 2013-12-16 JP JP2013259083A patent/JP2014077004A/ja active Pending
-
2016
- 2016-01-22 US US15/004,742 patent/US10216897B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013235610A5 (https=) | ||
| CY1120414T1 (el) | Αντισωματα που συνδεονται me οχ40 και οι χρησεις τους | |
| AU2018256487A1 (en) | Antibodies that bind to TL1A and their uses | |
| CY1124341T1 (el) | Ποντικοι me εξανθρωπισμενη καθολικη ελαφρια αλυσιδα | |
| UY37694A (es) | Dominios de unión a antígeno humanizados y métodos de uso | |
| CY1119335T1 (el) | Ποντικοι με περιορισμενη βαρια αλυσιδα ανοσοσφαιρινης | |
| CY1121545T1 (el) | Ποντικοι που εκφραζουν περιορισμενο ρεπερτοριο ελαφριων αλυσιδων ανοσοσφαιρινης | |
| CO6362024A2 (es) | Anticuerpos humanos de alta afinidad para el receptor il-4 humano | |
| FI3608337T3 (fi) | Bispesifisiä t-solua aktivoivia antigeenia sitovia molekyylejä | |
| CO6430469A2 (es) | Anticuerpos humanizados que se unen a cd19 y sus usos | |
| JP2018504907A5 (https=) | ||
| AR083747A1 (es) | Anticuerpos anti-il-23 | |
| AR095980A1 (es) | Anticuerpos biespecíficos específicos para fap (proteína de activación fibroblástica) y dr5 (receptor de muerte 5), anticuerpos específicos para dr5 y métodos de utilización | |
| FI2726510T3 (fi) | Kaksoiskohdennus | |
| JP2012511913A5 (https=) | ||
| MX2014002097A (es) | Anticuerpos bioespecificos especificos para antigenos que activan celulas t y un antigeno tumoral y metodos de uso. | |
| NZ605980A (en) | Anti-fap antibodies and methods of use | |
| MX384418B (es) | Constructo de anticuerpo de cadena individual biespecífico con distribución mejorada de tejido. | |
| PE20190737A1 (es) | Anticuerpos anti-cd27 | |
| HK1205873A1 (en) | Common light chain mouse | |
| WO2014012085A3 (en) | Bispecific asymmetric heterodimers comprising anti-cd3 constructs | |
| EA201291161A2 (ru) | Связывающие csf1r антитела | |
| MX2015012540A (es) | Ratón de cadena ligera común. | |
| DK201100184U1 (da) | Method for immunizing an avian species | |
| MX388698B (es) | Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171). |